Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION COMPRISING ATTENUATED STREPTOCOCCUS PNEUMONIAE STRAINS AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/199628
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition comprising attenuated Streptococcus pneumoniae strains, and a use thereof for prevention or treatment of inflammatory diseases, respiratory viral infections, bacterial infectious diseases, or allergic diseases.

Inventors:
RHEE DONG-KWON (KR)
SEON SEUNG-HAN (KR)
KIM BO-GYUNG (KR)
Application Number:
PCT/KR2018/004800
Publication Date:
November 01, 2018
Filing Date:
April 25, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV (KR)
International Classes:
A61K39/09; A61K9/00; A61K39/00; A61K39/39; A61K45/06; A61P11/06; A61P37/08
Foreign References:
KR20120010906A2012-02-06
KR20060108703A2006-10-18
KR101252911B12013-04-10
US8226959B22012-07-24
Other References:
ROCHE, A. M.: "Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice", INFECTION AND IMMUNITY, vol. 75, no. 5, May 2007 (2007-05-01), pages 2469 - 2475, XP002539036
PRESTON, J. A.: "Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells", EUROPEAN RESPIRATORY JOURNAL, vol. 37, no. 1, January 2011 (2011-01-01), pages 53 - 64, XP055032546
KNUDSON, C. J.: "The relationship between respiratory syncytical virus and asthma", VETERINARY PATHOLOGY, vol. 52, no. 1, January 2015 (2015-01-01), pages 97 - 106, XP055528676
CHOI SY ET AL.: "Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice", CLIN EXP VACCINE RES., 2013
See also references of EP 3616715A4
Attorney, Agent or Firm:
WIE, Byoung-Gap (KR)
Download PDF: